What is the current stock price of SenesTech, Inc. (SNES)?

As of the latest market data, SenesTech, Inc. (SNES) is trading at $1.60. The stock has seen a loss of -1.23% today.

Does SenesTech, Inc. (SNES) pay a dividend?

Based on current data, SenesTech, Inc. does not have a confirmed active dividend policy.

What is the market cap of SenesTech, Inc.?

The current market capitalization of SenesTech, Inc. (SNES) is approximately unavailable.

SNES

SenesTech, Inc.·Basic Materials

1.60

1.235%(−0.02)

Market Closed

1.62

1.250%(+0.02)

After Hours

Last Updated: — ET

52W L: $1.5452W H: $6.24

SNES NEWS

defenseworld.net

4d ago

Head-To-Head Analysis: Senestech (NASDAQ:SNES) vs. RBC Life Sciences (OTCMKTS:RBCL)

RBC Life Sciences (OTCMKTS:RBCL - Get Free Report) and Senestech (NASDAQ: SNES - Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk and valuation. Volatility and Risk RBC Life Sciences has a

defenseworld.net

Mar 14

Senestech, Inc. (NASDAQ:SNES) Short Interest Update

Senestech, Inc. (NASDAQ: SNES - Get Free Report) saw a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 49,411 shares, a growth of 127.9% from the February 12th total of 21,680 shares. Based on an average daily volume of 72,794 shares, the days-to-cover ratio is

seekingalpha.com

Mar 12

SenesTech, Inc. (SNES) Q4 2025 Earnings Call Transcript

prnewswire.com

Mar 12

SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce

SURPRISE, Ariz., March 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth quarter and the full year ended December 31, 2025.

prnewswire.com

Mar 9

SenesTech to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Thursday, March 12, 2026

Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX, March 9, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in birth control solutions for managing rodent populations, will report financial results for its fourth quarter and fiscal year 2025, ended December 31, 2025, after the market close on Thursday, March 12, 2026.

defenseworld.net

Mar 9

Reviewing Senestech (NASDAQ:SNES) & Omeros (NASDAQ:OMER)

Senestech (NASDAQ: SNES - Get Free Report) and Omeros (NASDAQ: OMER - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, dividends, valuation and profitability. Valuation and Earnings This table compares Senestech and Omeros"s

Company Profile

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Sector

Basic Materials

Industry

Chemicals - Specialty

Employees

IPO Date

2016-12-08

Beta

0.25

Websitewww.senestech.com↗